Cargando…

SARS-CoV-2 Delta variant isolates from vaccinated individuals

BACKGROUND: The SARS-CoV-2 Delta variant was first identified in the U.S. in March 2021 and has rapidly become the predominant lineage across the U.S. due to increased transmissibility, immune evasion and vaccine breakthrough. The aim of this study was to better understand the genetic diversity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkac, Lauren, Diepold, Sheila, Mitchell, Shane, Sarnese, Stephanie, Kolakowski, Lee F., Nelson, William M., Jennings, Katharine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166184/
https://www.ncbi.nlm.nih.gov/pubmed/35658876
http://dx.doi.org/10.1186/s12864-022-08652-z
_version_ 1784720548746493952
author Brinkac, Lauren
Diepold, Sheila
Mitchell, Shane
Sarnese, Stephanie
Kolakowski, Lee F.
Nelson, William M.
Jennings, Katharine
author_facet Brinkac, Lauren
Diepold, Sheila
Mitchell, Shane
Sarnese, Stephanie
Kolakowski, Lee F.
Nelson, William M.
Jennings, Katharine
author_sort Brinkac, Lauren
collection PubMed
description BACKGROUND: The SARS-CoV-2 Delta variant was first identified in the U.S. in March 2021 and has rapidly become the predominant lineage across the U.S. due to increased transmissibility, immune evasion and vaccine breakthrough. The aim of this study was to better understand the genetic diversity and the potential impact of mutations observed in SARS-CoV-2 viruses circulating in the U.S. in vaccinated individuals. RESULTS: Whole genome sequencing was performed on thirty-four SARS-CoV-2 positive samples using the Oxford Nanopore MinION. Evolutionary genomic analysis revealed two novel mutations, ORF1b:V2354F and a premature stop codon, ORF7a:Q94*, identified in a cluster of SARS-CoV-2 Delta isolates collected from vaccinated individuals in Colorado. The ORF1b:V2354F mutation, corresponding to NSP15:V303F, may induce a conformational change and result in a disruption to a flanking beta-sheet structure. The premature stop codon, ORF7a:Q94*, truncates the transmembrane protein and cytosolic tail used to mediate protein transport. This may affect protein localization to the ER-Golgi. In addition to these novel mutations, the cluster of vaccinated isolates contain an additional mutation in the spike protein, at position 112, compared to the Delta variant defining mutations. This mutation, S112L, exists in isolates previously obtained in the U.S. The S112L mutation substitutes a bulky hydrophobic side chain for a polar side chain, which results in a non-conservative substitution within the protein that may affect antibody-binding affinity. Additionally, the vaccinated cluster of isolates contains non-synonymous mutations within ORF8 and NSPs which further distinguish this cluster from the respective ancestral Delta variant. CONCLUSIONS: These results show there is an emerging sub-lineage of the ancestral Delta variant circulating in the U.S. As mutations emerge in constellations, those with a potentially beneficial advantage to the virus may continue to circulate while others will cease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08652-z.
format Online
Article
Text
id pubmed-9166184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91661842022-06-05 SARS-CoV-2 Delta variant isolates from vaccinated individuals Brinkac, Lauren Diepold, Sheila Mitchell, Shane Sarnese, Stephanie Kolakowski, Lee F. Nelson, William M. Jennings, Katharine BMC Genomics Research BACKGROUND: The SARS-CoV-2 Delta variant was first identified in the U.S. in March 2021 and has rapidly become the predominant lineage across the U.S. due to increased transmissibility, immune evasion and vaccine breakthrough. The aim of this study was to better understand the genetic diversity and the potential impact of mutations observed in SARS-CoV-2 viruses circulating in the U.S. in vaccinated individuals. RESULTS: Whole genome sequencing was performed on thirty-four SARS-CoV-2 positive samples using the Oxford Nanopore MinION. Evolutionary genomic analysis revealed two novel mutations, ORF1b:V2354F and a premature stop codon, ORF7a:Q94*, identified in a cluster of SARS-CoV-2 Delta isolates collected from vaccinated individuals in Colorado. The ORF1b:V2354F mutation, corresponding to NSP15:V303F, may induce a conformational change and result in a disruption to a flanking beta-sheet structure. The premature stop codon, ORF7a:Q94*, truncates the transmembrane protein and cytosolic tail used to mediate protein transport. This may affect protein localization to the ER-Golgi. In addition to these novel mutations, the cluster of vaccinated isolates contain an additional mutation in the spike protein, at position 112, compared to the Delta variant defining mutations. This mutation, S112L, exists in isolates previously obtained in the U.S. The S112L mutation substitutes a bulky hydrophobic side chain for a polar side chain, which results in a non-conservative substitution within the protein that may affect antibody-binding affinity. Additionally, the vaccinated cluster of isolates contains non-synonymous mutations within ORF8 and NSPs which further distinguish this cluster from the respective ancestral Delta variant. CONCLUSIONS: These results show there is an emerging sub-lineage of the ancestral Delta variant circulating in the U.S. As mutations emerge in constellations, those with a potentially beneficial advantage to the virus may continue to circulate while others will cease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-022-08652-z. BioMed Central 2022-06-04 /pmc/articles/PMC9166184/ /pubmed/35658876 http://dx.doi.org/10.1186/s12864-022-08652-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Brinkac, Lauren
Diepold, Sheila
Mitchell, Shane
Sarnese, Stephanie
Kolakowski, Lee F.
Nelson, William M.
Jennings, Katharine
SARS-CoV-2 Delta variant isolates from vaccinated individuals
title SARS-CoV-2 Delta variant isolates from vaccinated individuals
title_full SARS-CoV-2 Delta variant isolates from vaccinated individuals
title_fullStr SARS-CoV-2 Delta variant isolates from vaccinated individuals
title_full_unstemmed SARS-CoV-2 Delta variant isolates from vaccinated individuals
title_short SARS-CoV-2 Delta variant isolates from vaccinated individuals
title_sort sars-cov-2 delta variant isolates from vaccinated individuals
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166184/
https://www.ncbi.nlm.nih.gov/pubmed/35658876
http://dx.doi.org/10.1186/s12864-022-08652-z
work_keys_str_mv AT brinkaclauren sarscov2deltavariantisolatesfromvaccinatedindividuals
AT diepoldsheila sarscov2deltavariantisolatesfromvaccinatedindividuals
AT mitchellshane sarscov2deltavariantisolatesfromvaccinatedindividuals
AT sarnesestephanie sarscov2deltavariantisolatesfromvaccinatedindividuals
AT kolakowskileef sarscov2deltavariantisolatesfromvaccinatedindividuals
AT nelsonwilliamm sarscov2deltavariantisolatesfromvaccinatedindividuals
AT jenningskatharine sarscov2deltavariantisolatesfromvaccinatedindividuals